Low carbonyl reductase 1 expression is associated with poor prognosis in patients with oral squamous cell carcinoma

Carbonyl reductase 1 (CBR1) is an enzyme that catalyzes the reduction of numerous compounds by using NADPH-dependent oxidoreductase activity. Decreased expression of CBR1 is associated with disease progression and an unfavorable outcome in several types of malignancies. The purpose of the current st...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamanouchi, Ryota, Harada, Koji, Ferdous, Tarannum, Ueyama, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795658/
https://www.ncbi.nlm.nih.gov/pubmed/29456845
http://dx.doi.org/10.3892/mco.2018.1548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795658/
https://www.ncbi.nlm.nih.gov/pubmed/29456845
http://dx.doi.org/10.3892/mco.2018.1548

Ejemplares similares